Investigation of Complement Activation Product C4d as a Diagnostic and Prognostic Biomarker for Lung Cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Investigation of Complement Activation Product C4d as a Diagnostic and Prognostic Biomarker for Lung Cancer
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 105, Issue 18, Pages 1385-1393
Publisher
Oxford University Press (OUP)
Online
2013-08-13
DOI
10.1093/jnci/djt205
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic and Pharmacologic Inhibition of Complement Impairs Endothelial Cell Function and Ablates Ovarian Cancer Neovascularization
- (2015) Selene Nunez-Cruz et al. NEOPLASIA
- C1q Binds Phosphatidylserine and Likely Acts as a Multiligand-Bridging Molecule in Apoptotic Cell Recognition
- (2014) H. Paidassi et al. JOURNAL OF IMMUNOLOGY
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The State of Molecular Biomarkers for the Early Detection of Lung Cancer
- (2012) M. Hassanein et al. Cancer Prevention Research
- Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression
- (2012) Leticia Corrales et al. JOURNAL OF IMMUNOLOGY
- Pros and cons for C4d as a biomarker
- (2012) Danielle Cohen et al. KIDNEY INTERNATIONAL
- Immunotherapy for Non-small Cell Lung Cancer: Novel Approaches to Improve Patient Outcome
- (2011) Frances A. Shepherd et al. Journal of Thoracic Oncology
- Combined VEGF-A and VEGFR-2 concentrations in plasma: Diagnostic and prognostic implications in patients with advanced NSCLC
- (2011) Eloisa Jantus-Lewintre et al. LUNG CANCER
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer
- (2011) Mattia Boeri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Complement Factor H Is Elevated in Bronchoalveolar Lavage Fluid and Sputum from Patients with Lung Cancer
- (2010) R. Pio et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Cancer and the Complement Cascade
- (2010) M. J. Rutkowski et al. MOLECULAR CANCER RESEARCH
- New insights into the molecular mechanisms of classical complement activation
- (2010) Mihaela Kojouharova et al. MOLECULAR IMMUNOLOGY
- Complement: a key system for immune surveillance and homeostasis
- (2010) Daniel Ricklin et al. NATURE IMMUNOLOGY
- Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack
- (2009) Marcin Okroj et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Modulation of the antitumor immune response by complement
- (2008) Maciej M Markiewski et al. NATURE IMMUNOLOGY
- Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors
- (2007) Marcin Okroj et al. MOLECULAR IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started